Pharma & Biotech
The ayes and nays of ‘covered’ and ‘disclosed’ in a patent31 August 2021
AstraZeneca AB filed an application at the Delhi High Court seeking an interim injunction for restraining Emcure Pharmaceuticals Ltd. from making, selling, distributing, exporting or offering for sale products comprising the compound Ticagrelor under...
Patentability of inventions relating to dosing regimen in China31 August 2021
Although methods for the diagnosis and treatment of diseases are not granted patent rights in China, the CNIPA will allow an applicant to seek protection for inventions relating to the second medical use of a substance. Jiancheng Jiang explains the i...
Number of IP Filings In The Philippines Increaes By 20% In First Half30 August 2021
The total number of IP applications was 22,919. The most significant rise was in utility model (UM) submissions, which increased by 26% from 592 to 744 between January and June of last year.
Favipiravir: Patent rejection in Thailand31 July 2021
Thailand’s Department of Intellectual Property (DIP) has since rejected a Thai patent application filed under the compulsory license system for a specific formulation Favipiravir in tablet form.
One of Taiwan’s new Covid-19 vaccines can be a game changer05 July 2021
A local expert dissects one of the patent applications and provides updates on other vaccines that are currently being developed in the jurisdiction.
Asia IP’s editorial team reveals China’s top IP firms, practices30 April 2021
And the winners of the 2021 Asia IP China Awards are...
Uses of a patent28 February 2021
An in-depth look into second medical use patents, with exclusive insight from IP experts across the region.
2020 Asia IP Awards: And the winners are...31 January 2021
In a truly unprecedented year for all, which IP firms stood out from the crowd?